Literature DB >> 10649343

Broadening the Aldolase Catalytic Antibody Repertoire by Combining Reactive Immunization and Transition State Theory: New Enantio- and Diastereoselectivities.

.   

Abstract

Nine efficient aldolase antibodies were generated by using hapten 1. This hapten unites reactive immunization and the transition state analogue approach in a single molecule. Characterization of two of these antibodies reveals that they are highly proficient (up to 1000-fold better than any other antibody catalyst) and enantioselective catalysts for aldol and retro-aldol reactions and exhibit enantio- and diastereoselectivities opposite to that of antibody 38C2.

Year:  1999        PMID: 10649343     DOI: 10.1002/(sici)1521-3773(19991216)38:24<3738::aid-anie3738>3.0.co;2-2

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  20 in total

1.  Chemically programmed monoclonal antibodies for cancer therapy: adaptor immunotherapy based on a covalent antibody catalyst.

Authors:  Christoph Rader; Subhash C Sinha; Mikhail Popkov; Richard A Lerner; Carlos F Barbas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-17       Impact factor: 11.205

2.  Targeting cell surface alpha(v)beta(3) integrin increases therapeutic efficacies of a legumain protease-activated auristatin prodrug.

Authors:  Yuan Liu; Krishna Mohan Bajjuri; Cheng Liu; Subhash C Sinha
Journal:  Mol Pharm       Date:  2011-11-22       Impact factor: 4.939

3.  Expanding the concept of chemically programmable antibodies to RNA aptamers: chemically programmed biotherapeutics.

Authors:  Ulrich Wuellner; Julia I Gavrilyuk; Carlos F Barbas
Journal:  Angew Chem Int Ed Engl       Date:  2010-08-09       Impact factor: 15.336

4.  Multiple catalytic aldolase antibodies suitable for chemical programming.

Authors:  Rajib Kumar Goswami; Zheng-Zheng Huang; Jane S Forsyth; Brunhilde Felding-Habermann; Subhash C Sinha
Journal:  Bioorg Med Chem Lett       Date:  2009-04-18       Impact factor: 2.823

5.  Instant immunity through chemically programmable vaccination and covalent self-assembly.

Authors:  Mikhail Popkov; Beatriz Gonzalez; Subhash C Sinha; Carlos F Barbas
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

6.  Preparation and activities of macromolecule conjugates of the CCR5 antagonist Maraviroc.

Authors:  Shigehiro Asano; Julia Gavrilyuk; Dennis R Burton; Carlos F Barbas
Journal:  ACS Med Chem Lett       Date:  2014-02-13       Impact factor: 4.345

7.  Synthesis of the next-generation therapeutic antibodies that combine cell targeting and antibody-catalyzed prodrug activation.

Authors:  Sunny Abraham; Fang Guo; Lian-Sheng Li; Christoph Rader; Cheng Liu; Carlos F Barbas; Richard A Lerner; Subhash C Sinha
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

8.  Direct observation of an enamine intermediate in amine catalysis.

Authors:  Xueyong Zhu; Fujie Tanaka; Richard A Lerner; Carlos F Barbas; Ian A Wilson
Journal:  J Am Chem Soc       Date:  2009-12-30       Impact factor: 15.419

9.  Can we measure catalyst efficiency in asymmetric chemical reactions? A theoretical approach.

Authors:  Shaimaa El-Fayyoumy; Matthew H Todd; Christopher J Richards
Journal:  Beilstein J Org Chem       Date:  2009-11-19       Impact factor: 2.883

10.  Selection of phage-displayed peptides that bind to a particular ligand-bound antibody.

Authors:  Fujie Tanaka; Yunfeng Hu; Jori Sutton; Lily Asawapornmongkol; Roberta Fuller; Arthur J Olson; Carlos F Barbas; Richard A Lerner
Journal:  Bioorg Med Chem       Date:  2008-04-27       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.